CSBTF

Healthcare Medical Devices

Kuros Biosciences AG

$24.00
+0.00 +0.00% today Live

Price History

Not enough data
Price chart data
DatePrice
Oct 6, 2026, live at 10:56 AM ET24.00

Key Stats

Market Cap
952.16M
Avg Volume
60
P/E (TTM)
109.09
EPS
$0.22
52W High
$42.81
52W Low
$22.00
Div. Yield
0.0%

Valuation

P/B Ratio
10.77
P/S Ratio
5.44
EV/EBITDA
71.85
EV/Revenue
5.50

Margins

Gross Margin 86.4%
Operating Margin 5.6%
Net Margin 5.1%
EBITDA Margin 7.6%

Growth & Returns

Revenue Growth (YoY)
45.5%
Return on Equity
10.7%
Return on Assets
5.1%

Liquidity & Leverage

Current Ratio
1.87
Quick Ratio
1.22
Debt / Equity
0.11
Total Cash
9.73M
Total Debt
10.07M

About

Kuros Biosciences AG engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally. It operates through two segments, Medical Devices and Legacy Portfolio. The company provides MagnetOs Granules, an advanced bone graft based on the submicron needle-shaped NeedleGrip surface technology; MagnetOs Putty, a mold uses to fill bony voids for intervertebral disc space or posterolateral spine; and Attrax, a biphasic calcium phosphate bone grafts that mimic the porous and trabecular structure of cancellous bone, as well as checkmate licensing. The company was incorporated in 2016 and is headquartered in Schlieren, Switzerland.

kurosbio.com